Pentamethoxyamphetamine

Pentamethoxyamphetamine
Clinical data
Other names	PeMA; 2,3,4,5,6-Pentamethoxyamphetamine; 2,3,4,5,6-PeMA
ATC code	None;
Identifiers
	IUPAC name 1-(2,3,4,5,6-pentamethoxyphenyl)propan-2-amine;
CAS Number	23693-29-0;
PubChem CID	129681609;
Chemical and physical data
Formula	C14H23NO5
Molar mass	285.340 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=C(C(=C(C(=C1OC)OC)OC)OC)OC)N;
	InChI InChI=1S/C14H23NO5/c1-8(15)7-9-10(16-2)12(18-4)14(20-6)13(19-5)11(9)17-3/h8H,7,15H2,1-6H3; Key:CDUJLDXLXICILS-UHFFFAOYSA-N;

Pentamethoxyamphetamine (PeMA), also known as 2,3,4,5,6-pentamethoxyamphetamine (2,3,4,5,6-PeMA), is a chemical compound of the phenethylamine and amphetamine families related to the psychedelic drug mescaline (3,4,5-trimethoxyphenethylamine).^[1]^[2] It is the α-methyl or amphetamine derivative of pentamethoxyphenethylamine (PeMPEA).^[1]^[2] The compound does not seem to have been tested in animals or humans.^[1]^[2] However, the related drug PeMPEA is known to be behaviorally active in animal studies.^[1]^[3] PeMA was first described in the scientific literature by Alexander Shulgin by 1969.^[2]

Quick Facts Clinical data, Other names ...

See also